Residual Renal Function in Hemodialysis Patients: The Role of Angiotensin-Converting Enzyme Inhibitor in Its Preservation
ISRN Nephrology · 2013
DOI: 10.5402/2013/184527 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Nephrology, 2013. Verfasst von Dimitris Xydakis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Venizeleio Hospital, 71409 Heraklion, Crete, Greece. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Residual Renal function (RRF) has an important role in the overall morbidity and mortality in hemodialysis patients. The role of angiotensin-converting enzyme inhibitor (ACEi) in preserving renal function in chronic proteinuric nephropathies is well documented. We test the hypothesis that enalapril (an ACEi) slows the rate of decline of RRF in patients starting hemodialysis. A prospective, randomized open-label study was carried out. 42 patients were randomized in two groups either in treatment with enalapril or no treatment at all. Our study has proven that enalapril has a significant effect on preserving residual renal function in patients starting dialysis at least during the first 12 months from the initiation of the hemodialysis. Further studies are necessary in order to investigate the potential long-term effect of ACEi on residual renal function and on morbidity and mortality in patients starting hemodialysis.
Autor:innen und Institutionen
- Nephrology Department, Venizeleio Hospital, 71409 Heraklion, Crete, Greece.
- Nephrology Department, University Hospital of Heraklion, Voutes, 71100 Heraklion, Crete, Greece.
- Department of Biological Sciences, Molecular Medicine Research Center, University of Cyprus, University House "Anastasios G. Leventis," P.O. Box 20537, 1678 Nicosia, Cyprus.
Zitieren
APA
Xydakis, D., Papadogiannakis, A., Sfakianaki, M., Kostakis, K., Stylianou, K., Petrakis, I., Ergini, A., Voskarides, K., & Dafnis, E. (2013). Residual Renal Function in Hemodialysis Patients: The Role of Angiotensin-Converting Enzyme Inhibitor in Its Preservation. ISRN Nephrology. https://doi.org/10.5402/2013/184527
Vancouver
Xydakis D, Papadogiannakis A, Sfakianaki M, Kostakis K, Stylianou K, Petrakis I, et al. Residual Renal Function in Hemodialysis Patients: The Role of Angiotensin-Converting Enzyme Inhibitor in Its Preservation. ISRN Nephrology. 2013. doi:10.5402/2013/184527
BibTeX
@article{Xydakis2013,
author = {Xydakis, Dimitris and Papadogiannakis, Apostolos and Sfakianaki, Maria and Kostakis, Konstantinos and Stylianou, Konstantinos and Petrakis, Ioannis and Ergini, Antonaki and Voskarides, Konstantinos and Dafnis, Eugeneios},
title = {Residual Renal Function in Hemodialysis Patients: The Role of Angiotensin-Converting Enzyme Inhibitor in Its Preservation},
journal = {ISRN Nephrology},
year = {2013},
doi = {10.5402/2013/184527}
}
EUVIMED